Blog

  • Exxel Pharma Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

    Exxel Pharma Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

    – Video webcast now available on-demand

    AURORA, CO / ACCESS Newswire / July 22, 2025 / Exxel Pharma (“Exxel” or the “Company”), a pharmaceutical company dedicated to developing novel therapeutics for the treatment of neuronal hypersensitivity disorders, today announced Soren Mogelsvang PhD, President and Chief Executive Officer and Founder of Exxel, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference.

    As part of the event, Dr. Mogelsvang dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company’s programs in development.

    The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page of the Company’s website (exxelpharma.com).

    About Exxel Pharma

    Exxel Pharma is a privately held pharmaceutical company dedicated to developing novel therapeutics for the treatment of neuronal hypersensitivity disorders. The Company’s lead program, EX937, is a novel, oral, patented small molecule designed to specifically and peripherally inhibit the fatty acid amide hydrolase (FAAH) enzyme. Exxel plans to launch a first-in-human Phase 1/1b study of EX937 for the treatment of refractory chronic cough, a large underserved market with no current FDA-approved therapies. In preclinical studies, EX937 demonstrated efficacy in its ability to modulate chronic cough in multiple models. Additionally, EX937 has shown to have a favorable preclinical safety profile and is expected to have no CNS side effects by being entirely excluded from the central nervous system and brain. EX937 also has the potential to be utilized across a number of high-value indications, including hyperactive bladder, peripheral neuropathic pain and migraine headaches. Exxel Pharma has a second program (ARN compounds) with the potential to treat Social Anxiety and Autism Spectrum Disorder.

    Investor Contact
    Jenene Thomas
    Chief Executive Officer
    JTC Team, LLC
    T: 908.824.0775
    E: exxel@jtcir.com

    SOURCE: Exxel Pharma, Inc.

    View the original press release on ACCESS Newswire

  • enVVeno Medical Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

    enVVeno Medical Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

    – Video webcast now available on-demand

    IRVINE, CA / ACCESS Newswire / July 22, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of deep venous disease, today announced that Rob Berman, CEO of enVVeno, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference.

    As part of the segment, Mr. Berman dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company’s products in development.

    The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page of the enVVeno website, envveno.com.

    About enVVeno Medical Corporation
    enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company’s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the VenoValve U.S. pivotal study and the Company is currently performing the final testing necessary to seek approval for the pivotal trial for enVVe.

    INVESTOR CONTACT:
    Jenene Thomas, JTC Team, LLC
    NVNO@jtcir.com
    (908) 824-0775

    MEDIA CONTACT:
    Glenn Silver, FINN Partners
    Glenn.Silver@finnpartners.com
    (973) 818-8198

    SOURCE: enVVeno Medical Corporation

    View the original press release on ACCESS Newswire

  • iTolerance, Inc. Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

    iTolerance, Inc. Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

    – Video webcast now available on-demand

    MIAMI, FL / ACCESS Newswire / July 22, 2025 / iTolerance, Inc. (“iTolerance” or the “Company”), a biotechnology company focused on the development of innovative regenerative medicines, today announced that Dr. Anthony Japour, Chief Executive Officer of iTolerance, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference.

    As part of the event, Dr. Japour dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company’s programs in development.

    The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page of the Company’s website (itolerance.com).

    About iTolerance, Inc.

    iTolerance is a regenerative medicine company developing technologies to enable tissue, organoid or cell therapy without requiring life-long immunosuppression. Leveraging its proprietary biotechnology-derived Streptavidin-FasL fusion protein/biotin-PEG microgel (SA-FasL microgel) platform technology, iTOL-100, iTolerance is advancing a pipeline of programs using both allogenic cadaveric and stem cell-derived pancreatic islets to potentially cure Type 1 diabetes. Utilizing iTOL-100 to induce local immune tolerance, the Company is developing its lead indication as a potential cure for Type 1 Diabetes without the need for life-long immunosuppression. Additionally, the Company is developing iTOL-201 for treating liver failure by utilizing hepatocytes and iTOL-401 as a nanoparticle formulation for large organ transplants without the need for life-long immunosuppression. For more information, please visit itolerance.com.

    Investor Contact
    Jenene Thomas
    Chief Executive Officer
    JTC Team, LLC
    T: 908.824.0775
    iTolerance@jtcir.com

    Media Contact
    Susan Roberts
    T:202.779.0929
    sr@roberts-communications.com

    SOURCE: iTolerance, Inc.

    View the original press release on ACCESS Newswire

  • JTC Team Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference Now Live

    JTC Team Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference Now Live

    – Video webcasts from participating companies now available here

     

    FRENCHTOWN, NJ / ACCESS Newswire / July 22, 2025 / JTC Team (“JTC”), a fully integrated corporate communications and investor relations firm, today announced the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference is now live.

    For the event, management from the participating companies dove deeper into their dedication to their respective companies, how they got to where they are today and provided insight into why they are so passionate about the products and programs in development.

    The video webcasts from participating companies are now available:

    The on-demand presentations are available on the Virtual Investor website, as well as the Investor sections of the respective company websites.

    To access all Virtual Investor events, visit www.virtualinvestorco.com.

    JTC Team and Virtual Investor Co. are paid consultants to the participating companies. JTC Team and Virtual Investor Co. are investor relations and corporate communications firms. Any content included in this release shall not be construed as an offer to purchase securities of the applicable companies. Interested parties are responsible for conducting their own due diligence and are encouraged to review the companies’ websites and the SEC website for the latest information and filings on each company.

    About JTC Team

    JTC is a fully integrated investor relations firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on X and LinkedIn.

    Contact:

    Jenene Thomas
    JTC Team, LLC
    T: +1 (908) 824-0775
    jtc@jtcir.com

    SOURCE: JTC Team, LLC

    View the original press release on ACCESS Newswire

  • SMX Establishes Treasury Subsidiary to Advance Digital Asset Strategy in Wake of GENIUS Act

    SMX Establishes Treasury Subsidiary to Advance Digital Asset Strategy in Wake of GENIUS Act

    Formation of Treasury Subsidiary Marks Strategic Expansion as GENIUS Act Spurs Acceleration of SMX’s Blockchain and Digital Asset Vision

    NEW YORK, NY / ACCESS Newswire / July 22, 2025 / At SMX (Security Matters) (NASDAQ:SMX), we’ve spent years building the infrastructure to bring traceability, trust, and transparency to global supply chains. We didn’t wait for regulation to validate our vision-we built ahead of it. Now, with the recent signing of the GENIUS Act into U.S. law, our strategic roadmap is no longer just pioneering-it’s perfectly positioned.

    The GENIUS Act represents a historic milestone: the first comprehensive federal framework recognizing cryptocurrency and stablecoins in the world’s largest economy. For SMX, this legislation doesn’t prompt a pivot-it acts as an immediate accelerator to our long-standing digital asset strategy.

    As the next step in this progression, and as announced in a Form 6-K filing, SMX shall establish a new, wholly owned subsidiary in Ireland: SMX (Treasury and Digital Asset Holding Company) Limited. This new entity enables us to incorporate Bitcoin and other digital assets into our treasury operations, designed to protect value and mirror the same digital backbone that powers our core innovations.

    This isn’t a reaction to changing policy. It’s the continuation of our strategic mission – now aligned with a global regulatory shift toward digital economies.

    Our technology, including the Plastic Cycle Token (PCT), is already built on blockchain to provide verifiable, auditable tracking of materials from origin to end use. The PCT will offer brands a way to tangibly monetize circularity and meet global compliance standards through a secure, decentralized ledger. What others are now scrambling to create, we’ve already launched.

    The GENIUS Act, along with an expected follow-on bill anticipated this week, provides a more favorable environment for scaling these systems efficiently and legally. These laws don’t change our mission; they fast-track it.

    SMX was created to lead in a world where digital trust, material accountability, and decentralized verification would define commerce. That world is now here. And with this latest evolution of our treasury operations, we’re not just prepared-we’re leading.

    About SMX (Security Matters) Public Limited Company
    As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

    Forward-Looking Statements
    The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company’s fight against abusive and possibly illegal trading tactics against the Company’s stock; successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

    Media Contact For This Release:
    info@hawkpointmedia.com

    SOURCE: SMX (Security Matters) Public Limited

    View the original press release on ACCESS Newswire

  • Global Polymer Industries Redefines What’s Possible with Custom-Molded UHMW-PE

    Global Polymer Industries Redefines What’s Possible with Custom-Molded UHMW-PE

    Innovative Compression Molding Enables Complex Designs, Embedded Features, and Material Integration for OEMs Across Industries

    MADISON, SD / ACCESS Newswire / July 22, 2025 / Global Polymer Industries, a leader in advanced polymer solutions, is transforming what OEMs can expect from ultra-high molecular weight polyethylene (UHMW-PE). With proprietary custom molding capabilities, Global Polymer Industries now delivers net-shape molded UHMW-PE components that go far beyond traditional performance, offering unmatched durability, resistance, and design flexibility for demanding industrial applications.

    Unlike standard UHMW-PE sheets that require machining after production, Global Polymer’s compression molding technology forms parts to near-final shape from the outset. This unlocks a new world of manufacturing possibilities for OEMs looking to eliminate secondary processing, reduce costs, and improve part precision.

    Key advantages of Global Polymer’s custom molding process include:

    • Complex geometries with varying wall thicknesses in a single part

    • Molded-in logos, part numbers, or tracking features

    • Integration of additional materials, such as metal inserts, screws, or supports

    • The self-lubricating, impact-resistant, and low-friction benefits of UHMW-PE, customized for any end-use application

    “We’re not just shaping plastic-we’re shaping the future of manufacturing,” said Derek Mertz, Engineering R&D Manager at Global Polymer. “With our custom molding technology, OEMs gain design freedom that sheet-based UHMW-PE simply can’t provide, like variable thicknesses, molded-in part features, and integrated fasteners.”

    Global Polymer serves a wide range of industries, from forestry and food processing to wastewater, agriculture, and material handling, where component reliability, speed, and performance are mission-critical. By leveraging its unique compression molding process, the company helps OEMs streamline production, extend part life, and eliminate failure points caused by bolted or welded assemblies.

    To learn more about how custom-molded UHMW-PE can elevate your supply chain and production process, visit www.globalpolymer.com.

    About Global Polymer Industries

    Global Polymer is an industry leader in custom-molded UHMW-PE (Ultra High Molecular Weight Polyethylene) components, delivering innovative solutions to some of the world’s most demanding industries. From forestry and food processing to marine, mining, transportation, and manufacturing, Global Polymer partners with OEMs and manufacturers to engineer high-performance parts that stand up to wear, corrosion, and extreme environments. With a relentless focus on quality, precision, and customer collaboration, Global Polymer helps companies extend equipment life and improve efficiency. Learn more at www.globalpolymer.com.

    Media Contact:
    Global Polymer
    Phone: (605) 256-3150
    Website: www.globalpolymer.com
    Email: Emily Sorenson – emilys@henkinschultz.com

    SOURCE: Global Polymer Industries

    View the original press release on ACCESS Newswire

  • ZTEST Electronics Inc. Engages Integral Wealth Securities As Market Maker

    ZTEST Electronics Inc. Engages Integral Wealth Securities As Market Maker

    NORTH YORK, ON / ACCESS Newswire / July 22, 2025 / ZTEST Electronics Inc. (“ZTEST” or the “Company“) (CSE:ZTE)(OTCID:ZTSTF) is pleased to announce it has entered into an agreement dated July 22, 2025 (the “Agreement”) with Integral Wealth Securities Limited (“Integral”) to provide market-making services in compliance with the policies and guidelines of the Canadian Securities Exchange and other applicable legislation. The objectives of the services to be provided by Integral are to call a two-sided market; contribute to market liquidity and depth of the Company’s common shares; and maintain activity in the market.

    The Company and Integral are unrelated and unaffiliated entities. Integral and its clients may acquire an interest in the securities of the Company in the future. Integral will be responsible for the costs it incurs in buying and selling the Company’s common shares, and no third party will be providing funds or securities for the market making activities.

    Headquartered in Toronto, Integral is a national independent CIRO-licensed investment dealer, with recognised proficiencies in market making, wealth management and investment banking. The firm’s FINRA-regulated US broker dealer affiliate, Integral Wealth Securities LLC, is involved in investment banking and private placements.

    About ZTEST Electronics Inc.
    ZTEST Electronics Inc., through its wholly owned subsidiary Permatech Electronics Corporation (“Permatech”), offers Electronic Manufacturing Services (EMS) to a wide range of customers. Permatech’s offering includes Printed Circuit Board (PCB) Assembly, Materials Management and Testing services. Permatech operates from an ISO 9001:2015 certified facility in North York, Ontario, Canada. Permatech is a contract assembler of complex circuit boards, serving customers in the Medical, Power, Computer, Telecommunications, Wireless, Industrial, Trucking, Wearables and Consumer Electronics markets. It specializes in servicing customers who are looking for high yield and require high quality and rapid-turnaround on low and mid-volume production of high complexity products.

    For more information contact: Steve Smith, CEO (604) 837-3751 email: steves@ztest.com

    Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

    FORWARD-LOOKING STATEMENTS: This press release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward-looking statements are neither promises nor guarantees and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR+ in Canada (available at www.sedarplus.com).

    SOURCE: ZTEST Electronics Inc.

    View the original press release on ACCESS Newswire

  • Arrive AI Accelerates Growth with Post-Nasdaq Launch Hiring Initiative

    Arrive AI Accelerates Growth with Post-Nasdaq Launch Hiring Initiative

    INDIANAPOLIS, INDIANA / ACCESS Newswire / July 22, 2025 / Arrive AI (NASDAQ:ARAI) – a pioneering autonomous delivery network anchored by Arrive Points™ – is significantly expanding its team, with plans to triple its workforce by adding approximately 40 new team members. This strategic hiring initiative is a direct response to the company’s aggressive global expansion and scaling of its platform services.

    New roles will include artificial intelligence scientists, delivering on the company’s commitment to be AI first in its operation and deliverables. Other jobs will include software and product engineering, underscoring Arrive AI’s commitment to continuous refinements of its proprietary technology and patented products. Additional positions will support critical sales and marketing functions as the company prepares for widespread deployment. Most roles will be based at Arrive AI’s Fishers headquarters, reinforcing its roots in the Indiana economy with high-value job creation.

    “We’re an Indiana-born company and are very pleased to be able to bring the well-paying, highly rewarding jobs to the local economy,” said Arrive AI CEO Dan O’Toole. “As we work toward deployment, we’ll have huge opportunity for people who like to work fast, think out-of-the-box and who can see new uses for putting artificial intelligence to work.”

    The company, which debuted on the Nasdaq May 15, 2025, is preparing to deploy Arrive Points on a global basis and to provide platform services as it scales. Arrive AI and Skye Air recently announced plans for the platform to bring secure drone delivery to India. Other projects are in testing and early deployment stages for a hospital and specialty pharmacy deliveries in the United States.

    Arrive AI’s patented Autonomous Last Mile platform enables secure, efficient package delivery via drone, ground robot or human courier to and from its smart, AI-powered mailboxes. The platform provides real-time tracking, smart logistics alerts and advanced chain of custody controls to support shippers, delivery services and autonomous networks.

    “There’s no better time for innovative thinkers to join our team,” O’Toole said. “We’re looking for individuals ready to contribute significantly and help shape the future of autonomous logistics.”

    For more information and to apply, interested candidates can visit Arrive AI’s Careers page at arriveai.com/careers.

    -30-

    About Arrive AI: Arrive AI’s patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox, whether by drone, ground robot or human courier. The platform provides real-time tracking, smart logistics alerts and advanced chain of custody controls to support shippers, delivery services and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting and security systems to streamline the entire last-mile delivery experience. Learn more at www.arriveai.com.

    Media contact: Cheryl Reed at media@arriveai.com

    Investor Relations Contact: Alliance Advisors IR at ARAI.IR@allianceadvisors.com

    Cautionary Note Regarding Forward Looking Statements

    This news release and statements of Arrive AI’s management in connection with this news release or related events contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “potential”, “will”, “should”, “could”, “would”, “optimistic” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI’s Registration Statement for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

    SOURCE: Arrive AI Inc.

    View the original press release on ACCESS Newswire

  • Celebrating Culinary Craft: Bacio Trattoria Wins 2025 Consumer Choice Award for Italian Restaurants in Barrie

    Celebrating Culinary Craft: Bacio Trattoria Wins 2025 Consumer Choice Award for Italian Restaurants in Barrie

    BARRIE, ONTARIO / ACCESS Newswire / July 22, 2025 / Bacio Trattoria, a family-run Italian and Roman restaurant known for its authentic, handmade cuisine, has been recognized as the 2025 Consumer Choice Award winner in the Restaurants – Italian category in Barrie. This distinction reflects Bacio’s commitment to preserving tradition while creating a memorable and heartfelt dining experience for every guest.

    Located in the heart of downtown Barrie at 62 Dunlop Street West, Bacio Trattoria brings a piece of Italy to the local community-offering more than just food, but a connection to culture, family, and flavour. With its warm atmosphere, vintage lighting, mural of the Trevi Fountain, and walls lined with olive oil and Italian wines, the restaurant invites guests to experience a true taste of home.

    A Culinary Journey Rooted in Experience and Heritage
    Bacio Trattoria is led by Chef Francesca, who began her culinary journey in Rome at just 15 years old. With 37 years of experience in the food industry, she brings a depth of knowledge and a genuine passion for Italian cooking that is reflected in every dish.

    “I grew up in a kitchen where we cooked with what we had-fresh, simple, and from the heart,” says Chef Francesca. “That’s the way I still cook today. I want people to feel like they’re eating at my family’s table in Rome.”

    Homemade, Fresh, and Inspired by Rome
    The menu at Bacio Trattoria features a wide range of Italian and Roman dishes, all made in-house using carefully sourced ingredients. Guests can enjoy hand-rolled pastas, slow-simmered sauces, and rustic Roman favourites such as supplì-crispy rice balls with beef and cheese-and pork-and-beef risotto cakes. The menu also includes fresh seafood dishes, hearty risottos, and thin-crust Roman-style pizza baked to perfection.

    Each dish is crafted with intention, with options for multi-course tasting menus, vegetarian selections, and curated wine pairings available for those looking to experience the full spectrum of Italian dining.

    An Atmosphere That Feels Like Home
    Bacio’s motto, “guests arrive as customers and leave as family,” is more than a catchphrase-it’s a guiding principle. The restaurant’s size and layout create an intimate setting where staff take the time to learn guests’ names, dietary preferences, and favourite dishes. Whether it’s a couple’s date night, a group celebration, or a casual weekday meal, the atmosphere remains welcoming and personal.

    “We want guests to feel relaxed, taken care of, and full-like they just left Nonna’s house,” says Chef Francesca.

    Bacio also hosts private dining experiences and events, offering tailored menus and attentive service to make every occasion feel special. They are proud to maintain “SAFE” certification standards, ensuring that guests can dine with comfort and confidence.

    Locally Loved, Community Connected
    Since opening in Barrie, Bacio Trattoria has become a staple in the local food scene. The restaurant supports local vendors whenever possible, from produce and meats to wine selections, and has participated in community-driven events and fundraisers.

    Their commitment to consistency and care has earned them a steady stream of glowing reviews and word-of-mouth referrals, establishing them not only as a place to eat, but as a valued part of the neighbourhood.

    “This award means a lot because it reflects the trust our guests have in what we do-and that’s something we never take for granted,” says Chef Francesca.

    To explore the menu, inquire about events, or make a reservation, CLICK HERE or visit baciotrattoria.ca.

    About Consumer Choice Award:
    Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

    Contact Information:
    Sumi Saleh
    Communications Manager
    ssaleh@ccaward.com

    SOURCE: Consumer Choice Award

    View the original press release on ACCESS Newswire

  • Electrovaya Launches Multiple Battery System Products for New Robotic Vehicle Platforms with Three Leading OEMs

    Electrovaya Launches Multiple Battery System Products for New Robotic Vehicle Platforms with Three Leading OEMs

    Multiple battery system products launched for new robotic vehicle platforms for three distinct OEM customers with applications ranging from material handling to surveillance systems

    Part of a major product development effort to target the rapidly growing robotics segment, leveraging the Company’s technology advantages around battery safety and longevity

    TORONTO, ON / ACCESS Newswire / July 22, 2025 / Electrovaya Inc. (“Electrovaya” or the “Company”) (NASDAQ:ELVA)(TSX:ELVA), a lithium ion battery technology and manufacturing company, today announced that it has launched multiple battery system products for a variety of robotic vehicle platforms. These battery systems developed in collaboration with three major OEM partners, with 2 based in the USA and 1 in Japan for a variety of robotic vehicle applications ranging from material handling to surveillance applications. Initial deliveries to all three OEMs will begin in the current quarter with anticipated commercial deliveries accelerating from FY 2026 onwards.

    The battery solutions were developed to provide long run times, long life expectancy, rapid wireless charging capabilities and operate in 24/7 environments.

    “We are excited to launch these new customized solutions for the rapidly expanding robotic vehicle segment with some of the world leading OEMs in the segment in both the United States and Japan.” said Dr. Raj DasGupta, CEO of Electrovaya. “Robotics applications require the most reliable and long lasting battery technologies due to their continuous operating cycles and autonomous nature. We believe that the robotics sector is ideally aligned with our lithium-ion technology strengths and with the rapid rise in AI capabilities, subject to rapid growth. “

    For more information, please contact:

    Investor and Media Contact:
    Jason Roy
    VP, Corporate Development and Investor Relations
    Electrovaya Inc.
    jroy@electrovaya.com
    905-855-4618

    About Electrovaya Inc.
    Electrovaya Inc. (NASDAQ:ELVA)(TSX:ELVA) is a pioneering leader in the global energy transformation, focused on contributing to the prevention of climate change by supplying safe and long-lasting lithium-ion batteries without compromising energy and power. The Company has extensive IP and designs, develops and manufactures proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications. Electrovaya has two operating sites in Canada and a 52-acre site with a 137,000 square foot manufacturing facility in Jamestown New York state for its planned gigafactory. To learn more about how Electrovaya is powering mobility and energy storage, please explore www.electrovaya.com.

    Forward-Looking Statements
    This press release contains forward-looking statements, including statements that relate to, among other things, revenue, purchase orders, the potential for demand and orders from the described customers in FY 2026, order growth and customer demand in FY 2026 onwards, future business opportunities, and the ability to deliver to customer requirements, market size and growth potential. Forward-looking statements can generally, but not always, be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”, “possible”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “planned”, “objective”, “estimated” and “continue” (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, assumptions and analyses made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate are necessarily applied in making forward looking statements and such statements are subject to risks and uncertainties, therefore actual results may differ materially from those expressed or implied in such statements and undue reliance should not be placed on such statements. Material assumptions made in disclosing the forward-looking statements included in this news release include, but are not limited to assumptions that the Company’s customers will deploy its products in accordance with communicated timing and volumes, that the Company’s customers will complete new distribution centers in accordance with communicated expectations, intentions and plans, and stable political climate with respect to exports from Canada to the United. Factors that could cause actual results to differ materially from expectations include but are not limited to customers not placing roughly in accordance with historical ordering patterns and communicated intentions, the fact that the expected additional sales from the described customer are expressions of interest and not yet purchase orders, the uncertain effects of the imposition of a new tariff regime on Canadian exports by the United States, macroeconomic effects on the Company and its business and on the lithium battery industry generally, the Company’s liquidity and cash availability in excess of its operational requirements, and the ability to generate and sustain sales orders. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company’s Annual Information Form for the year ended September 30, 2023 under “Risk Factors”, in the Company’s base shelf prospectus dated September 17, 2024, and in the Company’s most recent annual and interim Management’s Discussion and Analysis under “Qualitative And Quantitative Disclosures about Risk and Uncertainties” as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.

    SOURCE: Electrovaya, Inc.

    View the original press release on ACCESS Newswire